The Ethics of Phase 0 Oncology Trials
Open Access
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (12), 3692-3697
- https://doi.org/10.1158/1078-0432.ccr-08-0876
Abstract
Recent guidance from the Food and Drug Administration supports the conduct of a new type of exploratory clinical trial, commonly called phase 0 clinical trials. Proponents argue that phase 0 clinical trials have the potential to expedite the development of new oncology drugs while exposing fewer research subjects to the risks of experimental treatments. At the same time, phase 0 oncology trials raise important ethical concerns that have received little attention. In particular, there is a question of whether it is ethical to enroll individuals in research that offers them no potential for clinical benefit. Further concern focuses on the inclusion of terminally ill and consequently vulnerable cancer patients in these trials. To evaluate these concerns, this article considers relevant empirical data from phase 1 oncology trials and develops several recommendations regarding the conduct of phase 0 clinical trials in oncology.Keywords
This publication has 47 references indexed in Scilit:
- Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to PatientClinical Cancer Research, 2008
- Patient Perspectives on Phase 0 Clinical TrialsClinical Cancer Research, 2008
- Designing Phase 0 Cancer Clinical TrialsClinical Cancer Research, 2008
- The Development of Phase I Cancer Trial Methodologies: the Use of Pharmacokinetic and Pharmacodynamic End Points Sets the Scene for Phase 0 Cancer Clinical TrialsClinical Cancer Research, 2008
- Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical PracticeMolecular Interventions, 2007
- The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trialsBritish Journal of Cancer, 2007
- Compressing drug development timelines in oncology using phase '0' trialsNature Reviews Cancer, 2007
- Phase I participants’ views of quality of life and trial participation burdensSupportive Care in Cancer, 2007
- Ethical Issues in Phase I Cancer Clinical TrialsInternational Journal of Pharmaceutical Medicine, 2006
- Patient motivation and informed consent in a phase I study of an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1984